Blueprint Medicines Corporation (BPMC) Surged 6.77% or 5.48 To Price $86.38 On Wednesday

Blueprint Medicines Corporation (BPMC) surged 6.77% or 5.48 to $86.38. It is about 425507 shares traded, which is 88.04% compare to the average total volume 483326. The market cap of BPMC is $3.79 billion. The year to date change is 1.11%. The 52 week price range is from $34.38 to $109.0. Price of BPMC have changed 1.26% during last week. It have changed -6.44% over last month, -2.00% over last 3 months, 25.84% over last 6 months and 97.75% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BPMC is 89.82. It is 3.98% above current price. The 200-day Moving Averages for BPMC is 73.55. It is -14.85% below current price. The 52-week High is 109.0. It is 26.19% from the current price. The 52-week Low is 34.38. It is -60.20% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of BPMC is 4.96 on 2018-04-30. Short % to float is 4.58%. There are some statistics of BPMC. It is has market cap $3.79 billion. The share outstanding is 43.84 million. The average volume is 483326. The revenue is 13.96M. It has 811.67M cash and 19.39M in debt. The percent of top 15 Institution holding is 98.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BPMC is -44.81%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BPMC is -36.93%.


Share this post